Luke Victor Miels
CEO & DirectorMr. Luke Victor Miels has been the Chief Executive Officer & Director at GSK plc and at GlaxoSmithKline LLC since January 01, 2026 and served as its Chief Commercial Officer from September 4, 2017 to January 01, 2026 and served as its President of Global Pharmaceuticals. Mr. Miels served as an Executive Vice-President of Europe at AstraZeneca PLC from August 2016 to January 25, 2017 and served as its Executive Vice President of Global Product & Portfolio Strategy, Global Medical Affairs and Corporate Affairs since May 2014 until August 2016 and its Executive Vice President of Global Portfolio & Product Strategy since May 7, 2014. His primary focus is business development, portfolio and product strategy, providing strategic direction from the product development stage through to commercialization. Mr. Miels served as Regional Vice President of Asia Pacific for the Roche Pharmaceuticals Division since 2009. He started his career in 1995 with Zeneca in Australia where he served as a Sales Representative and Product Manager for Plendil and Diprivan. He joined Aventis in 2000 as Marketing and Strategic Planning Manager in Australia before being appointed Country Manager for New Zealand in 2002 and Thailand the following year. He then transferred to the USA to lead the Analytics and Commercial Effectiveness function of Aventis US. Following the Sanofi-Aventis merger he led the integration office in the US and was appointed Vice President of Sales for Diabetes at the conclusion of the merger. In 2006, he moved to Basel to joined Roche as Head of Metabolism for Global Marketing. He was head of Asia for Roche based in Shanghai and then Singapore. He also co-chairs the Portfolio Investment Board with Hal. He served as a Director of Roche Products Pty Limited until May 1, 2014. Mr. Miels holds an MBA from the Macquarie University, Sydney and a Bachelor of Science degree in Biology from Flinders University in Adelaide.
Positions
- Company NameGSK plcStock CodeGSKPositionCEO & DirectorColleagues
- JBJulie Belita BrownCFO & Executive Director
- JRJonathan Richard SymondsChair
- JLJesse L. GoodmanScientific & Medical Expert
- SRShobie RamakrishnanChief Digital & Technology Officer
- TWTony WoodChief Scientific Officer and Head of R&D
- CACharles A. BancroftSenior Independent Non-Executive Director
- WMWendy Mira BeckerIndependent Non-Executive Director
